Commodore Capital as of June 30, 2026
Portfolio Holdings for Commodore Capital
Commodore Capital holds 33 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Relay Therapeutics (RLAY) | 13.4 | $225M | 12M | 18.71 | |
| Enliven Therapeutics (ELVN) | 9.9 | $166M | 3.3M | 50.75 | |
| Alkermes SHS (ALKS) | 9.4 | $157M | 3.0M | 52.40 | |
| Cogent Biosciences (COGT) | 7.0 | $118M | 3.1M | 38.70 | |
| Amylyx Pharmaceuticals (AMLX) | 6.0 | $102M | 5.7M | 17.96 | |
| Definium Therapeutics Com Shs (DFTX) | 5.6 | $94M | 2.0M | 47.04 | |
| Spyre Therapeutics Com New (SYRE) | 4.5 | $75M | 847k | 88.78 | |
| Alto Neuroscience Com Shs (ANRO) | 4.3 | $72M | 2.7M | 26.39 | |
| Tango Therapeutics (TNGX) | 4.2 | $70M | 2.3M | 31.26 | |
| Eyepoint Com New (EYPT) | 3.9 | $66M | 4.6M | 14.30 | |
| Tyra Biosciences (TYRA) | 3.6 | $60M | 1.9M | 31.94 | |
| Damora Therapeutics Com New (DMRA) | 3.0 | $50M | 1.9M | 26.01 | |
| Celldex Therapeutics Com New (CLDX) | 3.0 | $50M | 1.4M | 37.21 | |
| Pharvaris N V (PHVS) | 2.9 | $49M | 1.4M | 34.58 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 2.9 | $49M | 1.5M | 32.45 | |
| Assembly Biosciences Com New (ASMB) | 2.3 | $39M | 1.4M | 27.48 | |
| Editas Medicine (EDIT) | 1.7 | $29M | 8.9M | 3.24 | |
| Kymera Therapeutics (KYMR) | 1.7 | $29M | 250k | 114.67 | |
| Perspective Therapeutics Com New (CATX) | 1.3 | $22M | 6.3M | 3.41 | |
| Century Therapeutics (IPSC) | 1.3 | $21M | 8.7M | 2.45 | |
| Zura Bio Class A Ord Shs (ZURA) | 1.1 | $19M | 3.3M | 5.90 | |
| Avalo Therapeutics Com New (AVTX) | 1.1 | $19M | 1.0M | 18.48 | |
| Inflarx Nv (IFRX) | 1.0 | $16M | 7.3M | 2.24 | |
| An2 Therapeutics (ANTX) | 0.8 | $14M | 2.9M | 4.84 | |
| Nuvalent Inc-a (NUVL) | 0.7 | $12M | 100k | 123.50 | |
| Sab Biotherapeutics Com New (SABS) | 0.7 | $11M | 2.9M | 3.90 | |
| Inhibikase Therapeutics Com New (IKT) | 0.7 | $11M | 5.4M | 2.03 | |
| Relmada Therapeutics (RLMD) | 0.6 | $9.9M | 1.4M | 6.92 | |
| Pepgen (PEPG) | 0.5 | $8.1M | 4.5M | 1.80 | |
| Research Alliance Corp Iii Ord Shs Cl A | 0.3 | $5.4M | 500k | 10.70 | |
| Helix Acquisition Corp Iii Usd Cl A Ord Shs (HLXC) | 0.3 | $5.3M | 500k | 10.64 | |
| Athira Pharma (LONA) | 0.3 | $4.3M | 464k | 9.19 | |
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $630k | 2.8M | 0.23 |
